Authors: FERNANDEZMIRANDA C CANCELAS P DELACALLE A GOMEZ R MORENO E GOMEZGERIQUE J DELPALACIO A

Citation: C. Fernandezmiranda et al., CHANGES IN PHENOTYPES OF APOLIPOPROTEIN-E AND APOLIPOPROTEIN(A) IN LIVER-TRANSPLANT RECIPIENTS, Clinical transplantation, 11(4), 1997, pp. 325-327

Authors: FERNANDEZMIRANDA C MORALES JM PORRES A GOMEZGERIQUE J GUIJARRO C ARANDA JL ANDRES A RODICIO JL DELPALACIO A

Citation: C. Fernandezmiranda et al., INCREASED LIPOPROTEINS AND FIBRINOGEN IN CHRONIC RENAL-ALLOGRAFT DYSFUNCTION, American journal of nephrology, 17(5), 1997, pp. 445-449

Authors: PEREZ A CAIXAS A CARRERAS G MAURICIO D POU JM SERRAT J GOMEZGERIQUE J DELEIVA A

Citation: A. Perez et al., LIPOPROTEIN COMPOSITIONAL ABNORMALITIES IN TYPE-I DIABETES - EFFECT OF IMPROVED GLYCEMIC CONTROL, Diabetes research and clinical practice, 36(2), 1997, pp. 83-90

Authors: FERNANDEZMIRANDA C MORALES JM GUIJARO C ARANDA JL PORRES A GOMEZGERIQUE J

Citation: C. Fernandezmiranda et al., INCREASED LIPOPROTEINS AND FIBRINOGEN IN CHRONIC RENAL-ALLOGRAFT REJECTION, Atherosclerosis, 134(1-2), 1997, pp. 43-43

Authors: CARMENA R DEOYA M GOMEZGERIQUE J MATA P SERRANO S FRANCO M MARTINEZTRIGUERO ML ALVAREZSALA L MATESANZ J RUBIO MJ GRAS X OLIVAN J

Citation: R. Carmena et al., PRAVASTATIN, CHOLESTYRAMINE, AND BEZAFIBRATE IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - THE SPANISH MULTICENTER PRAVASTATIN STUDY, Cardiovascular risk factors, 6(1), 1996, pp. 55-61